Medicine guide
WAYRILZ
As listed in the register: WAYRILZ 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
400 mg · comprimido recubierto con película
- Prescription only
- Blood, clotting and anaemia
- Active substance
- Rilzabrutin
- Used in
- Blood, clotting and anaemia
- Made by
- Sanofi B.V.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Medicine groupBlood, clotting and anaemiaB02BX14
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Sanofi B.V. |
|---|---|
| Active substance | Rilzabrutin |
| Used in | Blood, clotting and anaemia |
| Strength | 400 mg |
| Form | comprimido recubierto con película |
| Classification | B02BX14 · Blood, clotting and anaemia |
| Route | vía oral |
| Marketed | No — authorised but not currently marketed, according to the register |
| Orphan medicine | Yes — designated for a rare disease, according to the register |
| Additional monitoring ▼ | Yes — under additional monitoring (black triangle). Report suspected side effects. |
| Name in the register | WAYRILZ 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA |
| Nº Registro | 1251974002 |
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician
Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.